Press "Enter" to skip to content

New patent for Opko Ireland drug RAYALDEE

0
Copyright © DrugPatentWatch. Originally published at New patent for Opko Ireland drug RAYALDEE

Annual Drug Patent Expirations for RAYALDEE
Annual Drug Patent Expirations for RAYALDEE

Rayaldee is a drug marketed by Opko Ireland Global and is included in one NDA. It is available from one supplier. There are eleven patents protecting this drug.

This drug has eigthy-eight patent family members in thirty-three countries.

The generic ingredient in RAYALDEE is calcifediol. One supplier is listed for this compound. Additional details are available on the calcifediol profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Opko Ireland drug RAYALDEE
    Do NOT follow this link or you will be banned from the site!